European Pharmaceutical Review

JANUARY 10, 2024

The gut microbiome: a therapeutic goldmine The potential of manipulating and harnessing the gut microbiome to treat and prevent disease, has seen a wave of clinical trials emerge” The human gut is a dynamic ecosystem saturated with a diverse array of bacteria, viruses, fungi and other microorganisms.

Medicine 52

Medicine Manufacturing Leads Networking 52

PM360

SEPTEMBER 28, 2022

In April 2022, we released an article describing proposed policies from the federal government that could impact prescription drug pricing. On August 16, 2022, President Biden signed the Inflation Reduction Act (IRA) into law. The IRA affects several components of the U.S. 35 insulin copay caps.

Government 97

Government Manufacturing Prescription Competition 97

pharmaphorum

JANUARY 9, 2023

The Roman god Janus, as we are frequently reminded in January, was two faced and able to look forward to the coming year and backward to reflect on the past one. Forecasters use terms like “unprecedented,” “inflection point,” and “transformative” when in forward-facing Janus mode. Things fall apart: deglobalisation.

Medicine 82

Medicine Healthcare Healthcare Pharma 82

Clarivate

AUGUST 8, 2023

Biogen CEO Chris Viehbacher referred to it as a potential drag on drug R&D. We are being forced to think about small molecule versus large molecule and how to get the biggest impact earliest.” The Biotech Industry Organization (BIO) called it “the Innovation Reduction Act.”

Biopharma 52

Biopharma Pharma Prescription Manufacturing 52

PM360

APRIL 25, 2023

The entirety of healthcare stakeholders is watching the biosimilars market closely because LOE events, particularly the Humira LOE, is likely to impact payers, providers, patients, and pharmaceutical manufacturers—both brand and biosimilar—and potentially society as a whole given the current controversy over rising drug prices.

Marketing 97

Marketing Competition Government Manufacturing 97

PM360

SEPTEMBER 7, 2023

After acquiring Intouch Group in December 2021, EVERSANA worked to combine the company with its own marketing agency EVERSANA ENGAGE and in June 2022 unveiled the newly combined EVERSANA INTOUCH. PM360: How has the transition gone of integrating Intouch Group and what has been the biggest benefit of the merger? but the teams have done a great job.

Medicine 52

Medicine Marketing Sales Engineering 52

Pharmaceutical Technology

FEBRUARY 1, 2023

As paediatric hospital wings are flooded with an unprecedented number of respiratory syncytial virus (RSV) cases , healthcare workers have been overwhelmed by an unusually early peak of the RSV season. According to the Centers for Disease Control and Prevention (CDC) , 45.8 According to the Centers for Disease Control and Prevention (CDC) , 45.8

Pharma 64

Pharma Pharmaceutical FDA Healthcare Provider 64

Clarivate

DECEMBER 14, 2023

PBMs in the spotlight Pharmaceutical benefit managers (PBMs) will be under the microscope in 2024, both in terms of how they manage certain drugs as well as the impact they have on drug pricing and buying. Five specific areas will bear monitoring as PBMs attempt to navigate a potentially choppy 2024.

Marketing 52

Marketing Healthcare Healthcare Insurance 52